Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Odrljin, T.
Right arrow Articles by Simpson-Haidaris, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Odrljin, T.
Right arrow Articles by Simpson-Haidaris, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain

TM Odrljin, JR Shainoff, SO Lawrence and PJ Simpson-Haidaris

Department of Medicine, University of Rochester, School of Medicine and Dentistry, NY, USA.

Thrombin (IIa)-cleavage of fibrinogen (FBG) to form polymerized fibrin promotes endothelial cell spreading, proliferation, and von Willebrand factor release, requiring the exposure of the beta 15-42 domain. Studies reported here indicate that IIa-cleavage of fibrinopeptide B enhances exposure of a heparin binding domain at the beta 15-42 neo-N- terminus of fibrin. Crossed immunoelectrophoresis showed heparin- induced mobility shifts indicative of complexing with FBG and with N- terminal CNBr fragments of FBG (NDSK) and of fibrin (IIa-NDSK), but not evidence of heparin complexing with FBG lacking B beta 1-42 or with FBG fragments D and E was seen. Elution from heparin-agarose with a linear gradient of NaCl showed that bound portions of both intact FBG and D fragments eluted below physiologic salt concentrations, whereas E3 fragments lacking B beta 1-53 did not bind. NDSK bound with higher affinity than did intact FBG, whereas binding of IIa-NDSK was maximal in this system. Binding of fibrin(ogen) to heparin agarose was saturable as well as inhibitable in a dose-dependent manner with both FBG and heparin. Scatchard analysis indicated a single class of binding site, with dissociation constants (kd) of 0.3 mumol/L for IIa-NDSK, 0.8 mumol/L for NDSK, and 18 mumol/L for FBG. Immobilized fibrin had twofold more heparin binding sites than did immobilized FBG and required a 5.5-fold higher concentration of heparin to inhibit by 50% the binding of labeled heparin. Together, the results indicate that IIa- cleavage results in enhanced exposure of two heparin binding domains (HBDs) with approximately threefold higher affinity in fibrin than in FBG. Synthetic peptide beta 15-42 showed highest binding to heparin- agarose followed by B beta 1-42, whereas peptides beta 18-31, beta 18- 27, and beta 24-42 did not bind. Thus, the primary structure of beta 15- 42 is required for specificity of heparin binding. Basic residues within the beta 15-32 region segregate primarily to one side of an alpha-helix in a helical wheel diagram, as is typical for authentic HBDs. Desulfated heparin and heparan sulfate bound more fibrin(ogen) than did other proteoglycans; however, heparin bound sixfold more Ila- NDSK than NDSK. These results confirm that fibrin binds to heparin with higher affinity than does FBG and that fibrin binding is not solely dependent on charge interactions of beta 15-42 with the negatively charged glycosaminoglycan.

Volume 88, Issue 6, pp. 2050-2061, 09/15/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
S. A. Smith and J. H. Morrissey
Polyphosphate enhances fibrin clot structure
Blood, October 1, 2008; 112(7): 2810 - 2816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. P. Michael, G. Sotiropoulou, G. Pampalakis, A. Magklara, M. Ghosh, G. Wasney, and E. P. Diamandis
Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression
J. Biol. Chem., April 15, 2005; 280(15): 14628 - 14635.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. J. Rybarczyk, S. O. Lawrence, and P. J. Simpson-Haidaris
Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration
Blood, December 1, 2003; 102(12): 4035 - 4043.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Pereira, B. J. Rybarczyk, T. M. Odrljin, D. C. Hocking, J. Sottile, and P. J. Simpson-Haidaris
The incorporation of fibrinogen into extracellular matrix is dependent on active assembly of a fibronectin matrix
J. Cell Sci., January 2, 2002; 115(3): 609 - 617.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. M. Odrljin, C. G. Haidaris, N. B. Lerner, and P. J. Simpson-Haidaris
Integrin {alpha}v{beta}3-Mediated Endocytosis of Immobilized Fibrinogen by A549 Lung Alveolar Epithelial Cells
Am. J. Respir. Cell Mol. Biol., January 1, 2001; 24(1): 12 - 21.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. Collen, S. M. Smorenburg, E. Peters, F. Lupu, P. Koolwijk, C. Van Noorden, and V. W. M. van Hinsbergh
Unfractionated and Low Molecular Weight Heparin Affect Fibrin Structure and Angiogenesis in Vitro
Cancer Res., November 1, 2000; 60(21): 6196 - 6200.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
R.D. Moreno and C. Barros
A Basic 18-Amino Acid Peptide Contains the Polysulfate-Binding Domain Responsible for Activation of the Boar Proacrosin/Acrosin System
Biol Reprod, June 1, 2000; 62(6): 1536 - 1542.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
B. J. Rybarczyk and P. J. Simpson-Haidaris
Fibrinogen Assembly, Secretion, and Deposition into Extracellular Matrix by MCF-7 Human Breast Carcinoma Cells
Cancer Res., April 1, 2000; 60(7): 2033 - 2039.
[Abstract] [Full Text]


Home page
BloodHome page
M. A. Olman, J. S. Hagood, W. L. Simmons, G. M. Fuller, C. Vinson, and K. E. White
Fibrin Fragment Induction of Plasminogen Activator Inhibitor Transcription Is Mediated by Activator Protein-1 Through a Highly Conserved Element
Blood, September 15, 1999; 94(6): 2029 - 2038.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. S. Retzinger, A. P. DeAnglis, and S. J. Patuto
Adsorption of Fibrinogen to Droplets of Liquid Hydrophobic Phases : Functionality of the Bound Protein and Biological Implications
Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1948 - 1957.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. L. Bach, C. Barsigian, C. H. Yaen, and J. Martinez
Endothelial Cell VE-cadherin Functions as a Receptor for the beta 15-42 Sequence of Fibrin
J. Biol. Chem., November 13, 1998; 273(46): 30719 - 30728.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. J. Simpson-Haidaris, M.-A. Courtney, T. W. Wright, R. Goss, A. Harmsen, and F. Gigliotti
Induction of Fibrinogen Expression in the Lung Epithelium during Pneumocystis carinii Pneumonia
Infect. Immun., September 1, 1998; 66(9): 4431 - 4439.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sahni, T. Odrljin, and C. W. Francis
Binding of Basic Fibroblast Growth Factor to Fibrinogen and Fibrin
J. Biol. Chem., March 27, 1998; 273(13): 7554 - 7559.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Guadiz, L. A. Sporn, and P. J. Simpson-Haidaris
Thrombin Cleavage-Independent Deposition of Fibrinogen in Extracellular Matrices
Blood, October 1, 1997; 90(7): 2644 - 2653.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
G. Guadiz, L. A. Sporn, R. A. Goss, S. O. Lawrence, V. J. Marder, and P. J. Simpson-Haidaris
Polarized Secretion of Fibrinogen by Lung Epithelial Cells
Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 60 - 69.
[Abstract] [Full Text]


Home page
BloodHome page
P. J. Simpson Haidaris
Induction of Fibrinogen Biosynthesis and Secretion From Cultured Pulmonary Epithelial Cells
Blood, February 1, 1997; 89(3): 873 - 882.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. M. Odrljin, C. W. Francis, L. A. Sporn, L. A. Bunce, V. J. Marder, and P. J. Simpson-Haidaris
Heparin-Binding Domain of Fibrin Mediates Its Binding to Endothelial Cells
Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1544 - 1551.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. C. Y. Liaw, D. L. Becker, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz
Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin
J. Biol. Chem., June 8, 2001; 276(24): 20959 - 20965.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020